文献速递牙体牙髓病

STING抑制减轻根尖周炎骨吸收

STING inhibition alleviates bone resorption in apical periodontitis.
PubMed 文献 · Int Endod J · 2024-02-27

该研究在小鼠根尖周炎模型中探讨靶向STING的免疫治疗作用。Sting-/-小鼠及STING抑制剂C-176处理小鼠的骨吸收、炎症浸润、RANKL表达及破骨细胞数量均减少,体外实验显示Sting-/-及C-176处理的骨髓巨噬细胞破骨分化受抑。STING在根尖周炎中被激活并促进骨丢失,C-176可缓解骨吸收。

要点

  • STING在根尖周炎F4/80+巨噬细胞中激活,促进破骨与骨丢失
  • C-176抑制STING可减轻小鼠根尖周炎症进展与骨吸收
  • Sting-/-及C-176处理抑制BMMs破骨分化及Src、Acp5表达

核心结论

  • STING在根尖周炎中被激活,是骨丢失与破骨细胞生成的促进因素。
  • STING抑制剂C-176可通过调节局部免疫反应减轻骨丢失,为根尖周炎提供免疫治疗思路。

研究设计与样本

  • 建立Sting-/-与野生型小鼠根尖周炎模型,体内采用micro-CT与H&E染色分析病变进展。
  • 用IHC与免疫荧光鉴定STING在F4/80+细胞中的表达与定位,IHC检测根尖周组织RANKL,TRAP染色检测破骨细胞。
  • 对根尖周炎小鼠给予STING抑制剂C-176,用H&E、TRAP、RANKL染色及micro-CT评估骨丢失。
  • 体外分离Sting-/-与野生型小鼠骨髓巨噬细胞(BMMs),在LPS诱导炎症环境中诱导破骨分化,并用C-176处理野生型BMMs。
  • 用TRAP染色与qRT-PCR检测破骨相关基因表达。

主要发现

  • 与野生型小鼠相比,暴露的Sting-/-小鼠骨吸收与炎症细胞浸润减少。
  • 暴露的野生型组中STING主要在F4/80+巨噬细胞中激活。
  • 组织学染色显示Sting-/-小鼠破骨细胞较少、破骨相关因子RANKL表达较低。
  • C-176处理根尖周炎小鼠减轻炎症进展与骨丢失,效果类似Sting-/-小鼠,且根尖周组织RANKL表达与破骨细胞数量减少。
  • 体外TRAP染色显示Sting-/-及C-176处理的BMMs破骨分化中阳性细胞减少,qRT-PCR显示破骨标志物Src与Acp5表达下降。

关键数值与推荐

  • 原文为机制研究,未报告可用于临床决策的阈值、剂量或推荐条款。

临床怎么用

  • 提示STING可能作为根尖周炎骨吸收的免疫治疗靶点,C-176在动物模型中显示减轻骨丢失的作用。
  • 目前证据限于小鼠与体外细胞实验,尚不能直接转化为临床用药方案。

局限性

  • 原文摘要未报告样本量、具体统计值与置信区间。
  • 证据来自小鼠模型与体外BMMs实验,尚未提供人体临床数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: The goal of this study was to investigate the potential effects of an immunotherapeutic drug targeting STING to suppress the overreactive innate immune response and relieve the bone defect in apical periodontitis. METHODOLOGY: We established an apical periodontitis mouse model in Sting-/- and WT mice in vivo. The progression of apical periodontitis was analysed by micro-CT analysis and H&E staining. The expression level and localization of STING in F4/80+ cells were identified by IHC and immunofluorescence staining. RANKL in periapical tissues was tested by IHC staining. TRAP staining was used to detect osteoclasts. To clarify the effect of STING inhibitor C-176 as an immunotherapeutic drug, mice with apical periodontitis were treated with C-176 and the bone loss was identified by H&E, TRAP, RANKL staining and micro-CT. Bone marrow-derived macrophages (BMMs) were isolated from Sting-/- and WT mice and induced to osteoclasts in a lipopolysaccharide (LPS)-induced inflammatory environment in vitro. Moreover, WT BMMs were treated with C-176 to determine the effect on osteoclast differentiation by TRAP staining. The expression levels of osteoclast-related genes were tested using qRT-PCR. RESULTS: Compared to WT mice, the bone resorption and inflammatory cell infiltration were reduced in exposed Sting-/- mice. In the exposed WT group, STING was activated mainly in F4/80+ macrophages. Histological staining revealed the less osteoclasts and lower expression of osteoclast-related factor RANKL in Sting-/- mice. The treatment of the STING inhibitor C-176 in an apical periodontitis mice model alleviated inflammation progression and bone loss, similar to the effect observed in Sting-/- mice. Expression of RANKL and osteoclast number in periapical tissues were also decreased after C-176 administration. In vitro, TRAP staining showed fewer positive cells and qRT-PCR reflected decreased expression of osteoclastic marker, Src and Acp5 were detected during osteoclastic differentiation in Sting-/- and C-176 treated BMMs. CONCLUSIONS: STING was activated and was proven to be a positive factor in bone loss and osteoclastogenesis in apical periodontitis. The STING inhibitor C-176 administration could alleviate the bone loss via modulating local immune response, which provided immunotherapy to the treatment of apical periodontitis.

来源:Int Endod J,查看原文。版权归原作者所有。

引用

  1. Mao HQ, Zhou L, Li JQ, et al. STING inhibition alleviates bone resorption in apical periodontitis. Int Endod J. 2024. PMID: 38411951. doi:10.1111/iej.14057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。